Mass Spectrometry & Spectroscopy
Updates to Spectrus® and Percepta® Platforms Released
Nov 05 2018
ACD has announced significant updates across its ACD/Spectrus and ACD/Percepta platforms. Version 2018.1 delivers greater functionality to all ACD/Labs products, including key tools for analytical and process chemists in pharmaceutical development, NMR spectroscopists, mass spectrometrists, plus LC and GC method development specialists.
“Scientific organisations expect a wealth of innovative capabilities in the applications they use to help them solve their most complex scientific challenges. But, they also expect those applications to be continually updated and improved.” said Andrew Anderson, Vice President of Innovation and Informatics Strategy at ACD/Labs. “This release offers a wealth of new and valuable functionality - we believe it represents a commitment to our customers to help them improve their productivity, provide deep scientific insight, and facilitate decision-making.”
ACD/Labs' v2018.1 software release includes the following updates:
Analytical Knowledge Management in Pharmaceutical Development - v2018.1 includes multiple requested features for Luminata™ and MetaSense™. Luminata now includes automated calculation of impurity carryover across stages, and improved handling of process schema imported from third-party drawing packages - including reagents and reactants. MetaSense users can now identify a greater number of metabolites through the addition of user-defined reactions, expand the scope of projects by analysing data from multiple different species (human, mouse, rat, dog) together, and accelerate reporting by utilising customisable reporting templates.
NMR and MS Dereplication - two new features to streamline identification of ‘known unknowns’ in both NMR and MS analysis. The Known Structure Identification NMR workflow, available as an add-on to both ACD/NMR Workbook Suite and ACD/Spectrus Processor, quickly determines whether experimental 13C spectra match predicted signals of known compounds. Similarly, improvements to the Intelligent Component Recognition workflow in ACD/MS Workbook Suite enable efficient identification of LC and GC known unknowns through batch spectral searching. Additional key NMR and MS updates include improved peak picking and multiplet assignment accuracy for 13C NMR spectra of fluorinated compounds, and upgraded MS Tree control to better visualise multiple MS spectra together.
Usability Improvements to Method Development Solutions - by consolidating functionality from across our various chromatography applications into two comprehensive method development and optimisation solutions: the improved ACD/AutoChrom, and the new ACD/Method Selection Suite. Particularly, Method Selection Suite combines physicochemical property predictions with method optimisation tools to define better starting conditions, estimate retention times, and optimise key separation parameters, all according to quality by design (QbD) principles.
Physicochemical and ADME/Tox Property Prediction - v2018.1 of the Percepta platform, which provides in silico predictions of physchem, ADME, and toxicity properties, includes significant improvements to our logP structure database (>1700 compounds added) to deliver more reliable and accurate logP estimates for novel compounds. Plus, this expansion also improves prediction tools that require logP - logD, oral bioavailability, blood-brain barrier penetration, and more.
For more information on ACD/Labs’ v2018.1 software updates, please visit
In this Edition Articles - Applications of Newly Developed 2.7 μm Porous Graphitic Carbon Particles in U/HPLC - Improve sensitivity and decrease matrix effects in pesticide residue analysis...
View all digital editions
Oct 19 2021 Kielce, Poland
Oct 19 2021 Liverpool, UK
Oct 19 2021 Basel, Switzerland
Oct 19 2021 New York, USA
Oct 19 2021 Kiev, Ukraine